Adriana M. Rauseo, MD

Assistant Professor of Medicine

Adriana Rauseo is an instructor in the division of infectious diseases.

Dr. Rauseo specializes in clinical infectious diseases, with a special focus on mycology and infectious that affect immunocompromised hosts. Since the outset of the COVID-19 pandemic she has served as an investigator in the Infectious Disease Clinical Research Unit (ID-CRU) in multiple clinical trials and translational research in the fight against COVID-19. In addition, she attends on the general infectious diseases consult service teaching fellows, residents, and students. She also sees patients in the general infectious diseases and virology clinic.

Related Links
Education
  • MD: Universidad Central de Venezuela, Luis Razetti School of Medicine, Caracas,Venezuela (2011)
  • Internal Medicine Residency: The University of Texas Health Science Center, McGovern Medical School, Houston TX (2018)
  • Infectious Diseases Fellowship: Washington University School of Medicine, St. Louis MO (2021)
Board Certifications
  • Diplomate, American Board of Internal Medicine
  • Diplomate, American Board of Internal Medicine, Infectious Diseases
Recognition
  • Resident of the Month 110% Award, Internal Medicine Residency at the University of Texas Health Science Center McGovern Medical School (2016)
  • Oral Presentation 3rd Place Award, American College of Physicians Texas Chapter Southeast Region Associates (2016)
  • Trainee Travel Award, Infectious Diseases Society of America (2019, 2020)
  • Open Forum Infectious Diseases editorial board member (2021)
Selected Publications
  1. Rauseo AM, Coler-Reilly A, Larson L, Spec A. Hope on the Horizon: Novel Fungal Treatments in Development. Open Forum Infect Dis. 2020 Feb;7(2):ofaa016. doi: 10.1093/ofid/ofaa016. eCollection 2020 Feb. Review. PubMed PMID: 32099843; PubMed Central PMCID: PMC7031074.
  2. Rauseo AM, Mazi P, Lewis P, Burnett B, Mudge S, Spec A. Bioavailability of Single-Dose SUBA-Itraconazole Compared to Conventional Itraconazole under Fasted and Fed Conditions. Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0013421. doi: 10.1128/AAC.00134-21. Epub 2021 Jul 16. PubMed PMID: 34031053.
  3. Turner JS, Kim W, Kalaidina E, Goss CW, Rauseo AM, Schmitz AJ, Hansen L, Haile A, Klebert MK, Pusic I, O’Halloran JA, Presti RM, Ellebedy AH. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021 Jul;595(7867):421-425. doi: 10.1038/s41586-021-03647-4. Epub 2021 May 24. PubMed PMID: 34030176.

Bibliography – Adriana Rauseo